Not applicableUnknownNCT02215577What this trial is testingALPPS Versus PVE/PLWho this might be right forColorectal CancerLiver Metastases Regionalt Cancercentrum Väst 100
Not applicableActive Not RecruitingNCT05524012What this trial is testingLongitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal CancerWho this might be right forLocally Advanced Rectal CarcinomaNeoadjuvant TreatmentRadiotherapy+1 more Jena University Hospital 40
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07542262What this trial is testingLow-dose Immunotherapy in Metastatic and Locally Advanced Colorectal and Gastric MSI/dMMR CancersWho this might be right forColorectal CancerGastric Cancer Blokhin's Russian Cancer Research Center 128
Testing effectiveness (Phase 2)WithdrawnNCT00003786What this trial is testingIrofulven in Treating Patients With Metastatic or Recurrent Colorectal CancerWho this might be right forColorectal Cancer University of Chicago
Early research (Phase 1)Ended earlyNCT06625515What this trial is testingFirst-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined CancersWho this might be right forAdvanced Solid TumorsBreast Cancer RecurrentColorectal Cancer Metastatic+3 more Accent Therapeutics 17
Not applicableStudy completedNCT01811108What this trial is testingAssessment of Clinical Practice Administration of Chemotherapy and Anti-angiogenic Agent (Bevacizumab) in Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Hellenic Oncology Research Group 670
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07260058What this trial is testingImmune Cell Therapy for Advanced Solid TumorsWho this might be right forLung Cancer (Locally Advanced or Metastatic)Liver Cancer (Locally Advanced or Metastatic)Colorectal Cancer (Locally Advanced or Metastatic)+2 more Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. 48
Early research (Phase 1)Looking for participantsNCT06657144What this trial is testingCHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid TumorsWho this might be right forMetastatic Solid TumorAdvanced Solid Tumor Coherus Oncology, Inc. 154
Early research (Phase 1)Study completedNCT02310464What this trial is testingTrial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer SubjectsWho this might be right forMetastatic Gastric CancerMetastatic Breast CancerMetastatic Colorectal Cancer+1 more OBI Pharma, Inc 25
Testing effectiveness (Phase 2)Looking for participantsNCT06540326What this trial is testingClinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or CetuximabWho this might be right forColorectal Cancer Metastatic Second Affiliated Hospital, Zhejiang University, School of Medicine 100
Early research (Phase 1)Study completedNCT01859858What this trial is testingEffect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid TumorsWho this might be right forAdvanced Colorectal Cancer UNC Lineberger Comprehensive Cancer Center 23
Early research (Phase 1)Study completedNCT03251378What this trial is testingA Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast CancersWho this might be right forAdvanced Solid TumorsMetastatic Colon CancerMetastatic Breast Cancer+4 more Hutchison Medipharma Limited 129
Early research (Phase 1)Active Not RecruitingNCT05462717What this trial is testingDose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid TumorsWho this might be right forNon-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma+1 more Revolution Medicines, Inc. 222
Early research (Phase 1)Study completedNCT01254617What this trial is testingLenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck CancerWho this might be right forRecurrent Colon CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+39 more National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT03565003What this trial is testingA First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in ChinaWho this might be right forNon-small Cell Lung CancerHead and Neck CancerEsophageal Cancer+1 more Jacobio Pharmaceuticals Co., Ltd. 126
Testing effectiveness (Phase 2)WithdrawnNCT04031872What this trial is testingLY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)Who this might be right forColorectal Cancer Metastatic The Netherlands Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT06051695What this trial is testingEvaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionWho this might be right forSolid Tumor, AdultColorectal CancerNSCLC+17 more A2 Biotherapeutics Inc. 474
Early research (Phase 1)WithdrawnNCT01605344What this trial is testingCrossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRIWho this might be right forAdvanced Adenocarcinoma of the Colon or Rectum UNC Lineberger Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00084721What this trial is testingIrinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal CancerWho this might be right forColorectal CancerDiarrhea Roswell Park Cancer Institute 2
Testing effectiveness (Phase 2)Study completedNCT00094809What this trial is testingChemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon CancerWho this might be right forColon CancerColorectal CancerRectal Cancer Amgen 252